1,526
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia

, PhDr. & , PhDr.

REFERENCES

  • Altman, L.K. 1987. Who Goes First? The Story of Self-Experimentation in Medicine. New York: Random House.
  • Barbosa, P.C.; Cazorlam, I.M.; Giglio, J.S. & Strassman, R. 2009. A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects. Journal of Psychoactive Drugs 41 (3): 205–12.
  • Barbosa, P.C.; Mizumoto, S.; Bogenschutz, M.P. & Strassman, R.J. 2012. Health status of ayahuasca users. Drug Testing and Analysis 4 (7–8): 601–9.
  • Bouso, J.C.; González, D.; Fondevila, S.; Cutchet, M.; Fernández, X.; Barbosa, P.C.; Alcázar-Córcoles, M.Á.; Araújo, W.S.; Barbanoj, M.J.; Fábregas, J.M. & Riba, J. 2012. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: A longitudinal study. PLoS One 7 (8): e42421.
  • Carhart-Harris, R.L.; Erritzoe, D.; Williams, T.; Stone, J.M.; Reed, L.J.; Colasanti, A.; Tyacke, R.J.; Leech, R.; Malizia, A.L.; Murphy, K.; Hobden, P.; Evans, J.; Feilding, A.; Wise, R.G. & Nutt, D.J. 2012. Neural correlates of the psychedelic state as determined by FMRI studies with psilocybin. Proc Natl Acad Sci USA 109: 2138–43.
  • Cohen, S. 1975. Drugs of Hallucination: The LSD Story. London: Granada Publishing Ltd.
  • DuToit, B.M. 1977. Drugs, Rituals and Altered States of Consciousness. Rotterdam: A.A. Balkema.
  • Frecska, E.; Móré, C.E.; Vargha, A. & Luna, L.E. 2012. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies. Journal of Psychoactive Drugs 44 (3): 191–9.
  • Griffiths, R.R.; Richards, W.A.; McCann, U. & Jesse, R. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187 (3): 268–83.
  • Grinspoon, L. & Bakalar, J.B. 1979. Psychedelic Drugs Reconsidered. New York: Basic Books.
  • Grob, C.S.; Danforth, A.L.; Chopra, G.S.; Hagerty, M.; Halberstad, A.L. & Greer, G.R. 2011. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 68 (1): 71–8.
  • Grof, S. 1964. K problematice optických poruch v autoexperimentech s halucinogeny [On the issue of optical disorders in auto-experiments with hallucinogens]. Československá Psychiatrie [Czechoslovak Psychiatry] 3: 173–81.
  • Grof, S. 1980. LSD Psychotherapy. Alameda, CA: Hunter House Publishers.
  • Grof, S. 1998. The Cosmic Game: Explorations of the Frontiers of Human Consciousness. New York: State University of New York Press.
  • Grof, S. 2007. Nové Perspektivy v Psychiatrii a Psychologii: Pozorování z Moderního Výzkumu Vědomí [New Perspectives in Psychiatry and Psychology: Observations from Modern Consciousness Research]. Prague: Knihovna ceny Nadace Dagmar a Václava Havlových, VIZE 97.
  • Grof, S. 2009. LSD: Doorway to the Numinous: The Groundbreaking Psychedelic Research into Realms of the Human Unconscious. Rochester, VT: Park Street Press.
  • Halpern, J.H.; Sherwood, A.R.; Passie, T.; Blackwell, K.C. & Ruttenber, A.J. 2008. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor 14 (8): 15–22.
  • Hausner, M. 1968. Research and Therapy with Psychodysleptics in Czechoslovakia (unpublished).
  • Hausner, M. 1993. LSD za železnou oponou [LSD behind the Iron Curtain]. Vokno [Window] 27: 94–7.
  • Hausner, M. & Doležal, V. 1971. Psychodysleptic Drugs in Czechoslovakia. Research, Therapy and Control. Prague: Joint Symposium on Social Psychiatry and Related Topics.
  • Hausner, M.; Grof, S. & Vojtěchovský, M. 1967. Zpráva o 2: Celostátním Semináři o Léčebném Využití Psychodysleptických Látek (unpublished).
  • Hausner, M. & Segal, E. 2009. LSD: The Highway to Mental Health. Malibu, CA: ASC Books.
  • Heffter Research Institute. 2012. Our Research. Available at: http://www.heffter.org/research-hucla.htm.
  • Hoffer, A. & Osmond, H. 1967. The Hallucinogens. New York: Academic Press.
  • Hofmann, A. 1980. LSD, My Problem Child. New York: McGraw-Hill.
  • Huxley, A. 1954. The Doors of Perception. New York: Harper & Row.
  • Johnson, M.W.; Richards, W.A. & Griffiths, R.R. 2008. Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology 22 (6): 603–20.
  • Krupitsky, E.M.; Burakov, A.M.; Dunaevsky, I.V.; Romanova, T.N.; Slavina, T.Y. & Grinenko, A.Y. 2007. Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. Journal of Psychoactive Drugs 39 (1): 13–9.
  • MacLean, K.A.; Johnson, M.W. & Griffiths, R.R. 2011. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 25 (11): 1453–1461.
  • Malleson, N. 1971. Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom. British Journal of Psychiatry 118 (543): 229–30.
  • Mangini, M. 1998. Treatment of alcoholism using psychedelic drugs: A review of the program of research. Journal of Psychoactive Drugs 30 (4): 381–418.
  • MAPS. 2009. MDMA Administration in a therapeutic setting in people who have completed the MAPS training program for therapists learning to conduct MDMA-assisted psychotherapy research in subject with PTSD. Protocol MT-1, IND #63-384. Available at: http://www.maps.org/mdma/mt1_docs/final_mt1_june_19_09.pdf.
  • Metzner, R. 1998. Hallucinogens in psychotherapy and shamanism. Journal of Psychoactive Drugs 30 (4): 1–10.
  • Mithoefer, M.C.; Wagner, M.T.; Mithoefer, A.T.; Jerome, L. & Doblin, R. 2011. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology 25 (4): 439–52.
  • Mithoefer, M.C.; Wagner, M.T.; Mithoefer, A.T.; Jerome, L.; Martin, S.F.; Yazar-Klosinski, B.; Michel, Y.; Brewerton, T.D. & Doblin, R. 2012. Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology 27 (1): 28–39.
  • Moreno, F.A.; Wiegand, C.B.; Taitano, E.K. & Delgado, P.L. 2006. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Journal of Clinical Psychiatry 67 (11): 1735–40.
  • Móró, L.; Simon, K.; Bárd, I. & Rácz, J. 2011. Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. Journal of Psychoactive Drugs 43 (3): 188–98.
  • Nevole, S. 1947. O Čtyřrozměrném Vidění: Studie z Fysiopathologie Smyslu Prostorového, se Zvláštním Zřetelem k Experimentální Otravě Mezkalinem [On Four-Dimensional Sight: Studies from Physiopathology of Space Sensorium, with Special Regards to Experimental Mescaline Poisoning]. Prague: Lékařské Knihkupectví a Nakladatelství.
  • Nevole, S. 1949. O Smyslových Ilusích a o Jejich Formální Genesi [On Sensory Illusions and Their Formal Genesis]. Prague: Zdravotnické Nakladatelství Spolku Lékařů a Vědeckých Pracovníků J. E. Purkyně.
  • Riba, J. & Barbanoj, M.J. 2005. Bringing ayahuasca to the clinical research laboratory. Journal of Psychoactive Drugs 37 (2): 219–30.
  • Riba, J.; McIhenny, E.H.; Valle, M.; Bouso, J.C. & Barker, S.A. 2012. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing and Analysis 4 (7–8): 610–6.
  • Riba, J.; Valle, M.; Urbano, G.; Yritia, M.; Morte, A. & Barbanoj, J. 2003. Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. The Journal of Pharmacology and Experimental Therapeutics 306 (1): 73–83.
  • Roof, W.C. 1999. Spiritual Marketplace: Baby Boomers and the Remaking of American Religion. Princeton, NJ: Princeton University Press.
  • Roubíček, J. 1961. Experimentální Psychosy [Experimental Psychosis]. Prague: Státní Zdravotnické Nakladatelství.
  • Sessa, B. 2005. Can psychedelics have a role in psychiatry once again? British Journal of Psychiatry 186: 457–8.
  • Strafford, P. 1992. Psychedelics Encyclopedia, 3rd ed. Berkeley, CA: Ronin Publishing.
  • Strassman, R.J. 1995. Hallucinogen drugs in psychiatric research and treatment: Perspectives and prospects. The Journal of Nervous and Mental Disease 183 (3): 127–38.
  • Trichter, S.; Klimo, J. & Krippner, S. 2009. Changes in spirituality among ayahuasca ceremony novice participants. Journal of Psychoactive Drugs 41 (2): 121–34.
  • Vojtěchovský, M. 1966. Co přináší pro psychiatra pokus s halucinogeny na sobě [What self-experimentation with hallucinogens can offer to a psychiatrist]. Československá Psychiatrie [Czechoslovak Psychiatry] 5: 303–7.
  • White, W.L. 2013. A life in addiction psychiatry: An interview with Dr. Herb Kleber. Available at: http://www.williamwhitepapers.com/pr/2013%20Dr.%20%20Herb%20Kleber.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.